报告从医药行业事件分析、竞争环境、竞争对手、行业数据等几个方面进行了分析评论。

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面进行了分析评论。

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面对医药行业进行了分析评论。

2014年1-5月，医药行业运行呈现以下特点：一是受大部分企业完成新版GMP认证和我国经济发展模式转变影响，医药行业固定资产投资增速继续下滑；二是医药行业积极转型，加大研发投入，加之外部环境有所改善，医药行业工业增加值情况开始好转；三是由于医药终端增长低于预期，医药零售增速继续下滑；四是出口额增速低位恢复，进口额进入相对平稳的增长轨道；五是受内外需求增长乏力、医保控费、环保支出增大等因素的影响，医药行业收入和利润增速进一步放缓。

《中国证券报》7月1日报道，环保整顿之下，持续低迷的维生素B1价格已经“咸鱼翻身”，持续涨价趋势渐明。维生素B1价格二季度一次性提价40%后，近期价格仍在上行。分析人士指出，环保整顿是此次价格上涨的导火索。4月初，因存在严重的水污染问题，江西乐平塔山工业园全面整顿，部分企业关停，其中江西天新药业是国内维生素B1主要供应商，在其降低开工率后，维生素B1产量缩减，供给紧张，随即开始涨价。

财新网6月18日消息，国家卫计委近日下发紧急通知控制公立医院规模过快扩张。目前各地卫计委正在对公立医院的床位规模和建设项目进行全面排查。 《关于控制公立医院规模过快扩张的紧急通知》称，近年来，中国公立医院规模过快扩张，部分医院单位规模过大，存在追求床位规模、竞相购置大型设备、忽视医院内部管理和机制建设等粗放式发展的问题，提高了医疗费用的不合理增长，挤压了基层医疗卫生机构与非公立医院的发展空间，也不利于医院提高服务质量和管理水平。

5月，医药规模生产规模有所扩大，其中中成药产量环比增长9.94%，化学原料药产量与上月基本持平。而中西药品类零售总额出现年内首降，环比下降2.4%，主要是受药品价格调控所致。在药品价格调控的引导下，医药制造业工业品出厂价格指数逐步趋稳，5月为100.73点，比上月下滑0.03点。下半年，随着各省药品招标进程逐步加快，下游需求将回暖，再加上行业政策逐渐明朗，企业将逐渐走出新版GMP认证带来的负面影响，预计医药行业发展速度将有所上升。

报告从医药行业事件分析、竞争环境、竞争对手、行业数据等几个方面进行了分析评论。

Hypercholesterolemia is a condition characterized by very high levels of total cholesterol and LDL cholesterol in the blood. High cholesterol levels, in turn, can lead to CVDs such as atherosclerosis and stroke. The normal physiological range of total blood cholesterol is 140-200 mg/dL. However, blood cholesterol consists of various individual components such as LDL cholesterol and HDL cholesterol. While LDL delivers cholesterol to the body, HDL removes cholesterol from the cells by reverse cholesterol transport to the liver. Owing to their distinct roles, these components are individually evaluated to determine the dyslipidemic status of an individual. FH is the inheritable form of hypercholesterolemia characterized by elevated levels of total cholesterol and LDL cholesterol. HeFH is the condition inherited because of the presence of one abnormal copy of the LDLR gene. HoFH is characterized by the presence of abnormal copies of both the LDLR alleles.

Endometriosis is a common feminine health condition where endometrial tissue, which is usually found inside the lining of the uterus, appears and grows outside the uterine cavity. Endometriosis can occur in the fallopian tubes, ovaries, the outer surface of the uterus, the pelvic cavity, vagina, cervix, and bladder. Endometriosis has, although rarely, been reported in other parts of the body such as the lungs, brain, and the skin. The most common symptoms associated with endometriosis are pelvic pain, dysmenorrhea, excessive bleeding, and lower abdominal pain. Less common symptoms of endometriosis are rectal bleeding and hematuria. The detection of endometriosis is difficult for the physician owing to the common symptoms associated with it. Endometriosis can be diagnosed by laparoscopy, ultrasound, pelvic examination, and biopsy of the inner lining of the uterus. For a biopsy, tissue from the inner lining of the uterus of the patient is taken and tested using biomarkers for the presence of endometriosis. Endometriosis is a noncurable disease and might relapse after the primary treatment. Currently, the treatment options for endometriosis include the usage of analgesics for symptomatic relief and hormone therapy is used to control the disease.

A bone densitometer is an X-ray device used to measure the calcium content of the bone.

本刊以七大战略性新兴产业——节能环保、新一代信息技术、生物、高端装备制造、新能源、新材料、新能源汽车为研究重点，关注国家高层和各部委的动态，剖析国家和地方的新兴产业政策。本刊设有政策导读、领导讲话、七大战略性新兴产业本周国内外行业动态和重点企业新闻、投资专题四大板块，能够实时监测新兴产业和重点企业动态，把握新兴产业发展方向，研究发展重点，寻求发展机遇。